Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adenocarcinoma developing in an ileal conduit.
Sakano S, Yoshihiro S, Joko K, Kawano H, Naito K. Sakano S, et al. Among authors: joko k. J Urol. 1995 Jan;153(1):146-8. doi: 10.1097/00005392-199501000-00052. J Urol. 1995. PMID: 7966752 Review.
Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines.
Sakano S, Matsuyama H, Takai K, Yoshihiro S, Kamiryo Y, Shirataki S, Kaneda Y, Hashimoto O, Joko K, Suga A, Yamamoto M, Hayashida S, Baba Y, Aoki A; Yamaguchi Uro-Oncology Group. Sakano S, et al. Among authors: joko k. BJU Int. 2011 May;107(10):1598-604. doi: 10.1111/j.1464-410X.2010.09850.x. Epub 2010 Nov 18. BJU Int. 2011. PMID: 21087393
Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.
Hara T, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Nasu T, Joko K, Baba Y, Suga A, Yamamoto M, Aoki A, Takai K, Yoshihiro S, Konishi M, Sakano S, Imoto K, Tei Y, Yamaguchi S, Yano S; Yamaguchi Uro-Onocology Group. Hara T, et al. Among authors: joko k. Int J Clin Oncol. 2016 Feb;21(1):139-47. doi: 10.1007/s10147-015-0857-9. Epub 2015 Jun 16. Int J Clin Oncol. 2016. PMID: 26077140
[Does alpha1-blocker provide additional improvement of quality-of-life in patients with overactive bladder?--a multi-center prospective randomized trial between anti-cholinergic (propiverine chloride) with and without alpha1-blocker (urapidil)].
Matsuyama H, Shimizu Y, Kamiryo Y, Joko K, Shimabukuro T, Suga A, Takemoto M, Imoto K, Hara Y, Yamamoto N, Kaneda Y, Harada N, Naito K. Matsuyama H, et al. Among authors: joko k. Nihon Hinyokika Gakkai Zasshi. 2007 May;98(4):604-13. doi: 10.5980/jpnjurol1989.98.604. Nihon Hinyokika Gakkai Zasshi. 2007. PMID: 17564103 Free article. Clinical Trial. Japanese.
Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Sakano S, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Kaneda Y, Nasu T, Hashimoto O, Joko K, Baba Y, Shimabukuro T, Suga A, Yamamoto M, Aoki A, Takai K, Yoshihiro S, Matsumura M; Yamaguchi Uro-Oncology Group. Sakano S, et al. Among authors: joko k. Ann Surg Oncol. 2013 Dec;20(13):4389-96. doi: 10.1245/s10434-013-3259-0. Epub 2013 Sep 18. Ann Surg Oncol. 2013. PMID: 24046115
Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
Nagao K, Matsuyama H, Matsumoto H, Nasu T, Yamamoto M, Kamiryo Y, Baba Y, Suga A, Tei Y, Yoshihiro S, Aoki A, Shimabukuro T, Joko K, Sakano S, Takai K, Yamaguchi S, Akao J, Kitahara S; Yamaguchi Uro-Oncology Group. Nagao K, et al. Among authors: joko k. Int J Clin Oncol. 2018 Aug;23(4):757-764. doi: 10.1007/s10147-018-1272-9. Epub 2018 Mar 27. Int J Clin Oncol. 2018. PMID: 29589154 Free PMC article.
126 results